Literature DB >> 5470509

Lysis of erythrocytes by complement in the absence of antibody.

O Götze, H J Müller-Eberhard.   

Abstract

A new pathway of complement-mediated hemolysis has been described. It is independent of antibody and does not require binding of the first four complement components to the target-cell surface. The actual attack of the target cell begins with the attachment of C5, C6, and C7. The binding reaction is catalyzed by C4, 2, 3, an enzyme which may be formed in cell-free solution. C4, 2, 3 may effect binding of C5, 6, 7 by acting from the fluid phase or from the surface of another cell to which it is specifically bound (EAC 4, 2, 3). In either case, the resulting product is EC5, 6, 7 which is susceptible to lysis by C8 and C9. Erythrocytes from patients with paroxysmal nocturnal hemoglobinuria (PNH) were particularly susceptible to lysis by the above described mechanism. PNH cells, but not normal human erythrocytes, could also be lysed through activation of complement by cobra factor. These observations allow the operational distinction of an activation and an attack mechanism of complement.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5470509      PMCID: PMC2138874          DOI: 10.1084/jem.132.5.898

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  25 in total

1.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

2.  Studies on the mode of action of the fifth, sixth and seventh component of human complement in immune haemolysis.

Authors:  U R Nilsson; H J Müller-Eberhard
Journal:  Immunology       Date:  1967-07       Impact factor: 7.397

3.  Hemolysin titration based on fixation of the activated first component of complement: evidence that one molecule of hemolysin suffices to sensitize an erythrocyte.

Authors:  T Borsos; H J Rapp
Journal:  J Immunol       Date:  1965-09       Impact factor: 5.422

4.  Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. I. The sensitivity of PNH red cells to lysis by complement and specific antibody.

Authors:  W F Rosse; J V Dacie
Journal:  J Clin Invest       Date:  1966-05       Impact factor: 14.808

5.  Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.

Authors:  R A Nelson; J Jensen; I Gigli; N Tamura
Journal:  Immunochemistry       Date:  1966-03

6.  The second component of human complement: its isolation, fragmentation by C'1 esterase, and incorporation into C'3 convertase.

Authors:  M J Polley; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1968-09-01       Impact factor: 14.307

7.  Enharncement of the hemolytic activity of the second component of human complement by oxidation.

Authors:  M J Polley; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1967-12-01       Impact factor: 14.307

8.  The conversion of C'IS to C'1 esterase by plasmin and trypsin.

Authors:  O D Ratnoff; G B Naff
Journal:  J Exp Med       Date:  1967-02-01       Impact factor: 14.307

9.  Deficiency of the sixth component of complement in rabbits with an inherited complement defect.

Authors:  K Rother; U Rother; H J Müller-Eberhard; J R Nilsson
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

10.  The reaction mechanism of beta-1C-globulin (C'3) in immune hemolysis.

Authors:  H J Müllerèberhard; A P Dalmasso; M A Calcott
Journal:  J Exp Med       Date:  1966-01-01       Impact factor: 14.307

View more
  58 in total

1.  Binding of the complement intermediate C56 to zymosan in acute phase human sera.

Authors:  P J Baker; L G Rubin; T F Lint; B C McLeod; H Gewurz
Journal:  Clin Exp Immunol       Date:  1975-04       Impact factor: 4.330

2.  Increased ion permeability of planar lipid bilayer membranes after treatment with the C5b-9 cytolytic attack mechanism of complement.

Authors:  D W Michaels; A S Abramovitz; C H Hammer; M M Mayer
Journal:  Proc Natl Acad Sci U S A       Date:  1976-08       Impact factor: 11.205

3.  On the mechanism of cytolysis by complement: evidence on insertion of C5b and C7 subunits of the C5b,6,7 complex into phospholipid bilayers of erythrocyte membranes.

Authors:  C H Hammer; A Nicholson; M M Mayer
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

4.  Membrane attack complex generation increases as a function of time in stored blood.

Authors:  X Hu; R P Patel; J A Weinberg; M B Marques; T N Ramos; S R Barnum
Journal:  Transfus Med       Date:  2014-03-04       Impact factor: 2.019

5.  Reaction of an activated complex of guinea-pig complement components, C56, with unsensitized erythrocytes and with erythrocytes carrying C3b molecule.

Authors:  N Tamura; A S Baba
Journal:  Immunology       Date:  1976-07       Impact factor: 7.397

6.  Autoimmunity to tropomyosin isoforms in ulcerative colitis (UC) patients and unaffected relatives.

Authors:  L Biancone; G Monteleone; R Marasco; F Pallone
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

7.  Studies on the inhibition of C56-initiated lysis (reactive lysis). III. Characterization of the inhibitory activity C567-INH and its mode of action.

Authors:  B McLeod; P Baker; H Gewurz
Journal:  Immunology       Date:  1975-01       Impact factor: 7.397

8.  Bystander mechanism for complement-initiated early oligodendrocyte injury in neuromyelitis optica.

Authors:  Lukmanee Tradtrantip; Xiaoming Yao; Tao Su; Alex J Smith; Alan S Verkman
Journal:  Acta Neuropathol       Date:  2017-05-31       Impact factor: 17.088

9.  Studies on the inhibition of C56-initiated lysis (reactive lysis). V. The roleof C567-INH in the regulation of complement-dependent haemolysis initiated by cobravenom factor.

Authors:  B McLeod; T F Lint; P Baker; C Behrends; H Gewurz
Journal:  Immunology       Date:  1975-04       Impact factor: 7.397

10.  Complement lysis of human erythrocytes. Differeing susceptibility of two types of paroxysmal nocturnal hemoglobinuria cells to C5b-9.

Authors:  C H Packman; S I Rosenfeld; D E Jenkins; P A Thiem; J P Leddy
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.